Expanded reimbursement for pharmacist services is something industry professionals and organizations have long advocated for. Since 2023, several states have passed legislation broadening the scope for such.
Expanded reimbursement for pharmacist services is something industry professionals and organizations have long advocated for. Since 2023, several states have passed legislation broadening the scope for such.
Once the continuous enrollment ends, it is estimated between 5 -14 million individuals will be affected
Three Healthcare Organizations Join Forces to Save Lives
Charitable Pharmacies of America organization member receives Health Equity grant
A Fireside Chat with AAM Chair, Christine Baeder and Mark Cuban, Entrepreneur and Cost Plus founder
The pharmacy industry sees at least five changes
One in four Americans say they struggle to afford their prescription medications. The establishment of this Charitable Pharmacy in Milford will allow patients who live east of Cincinnati better access to care.
An opportunity for charitable pharmacies to collaborate with oncology practices for non-oncology medications during and after treatment.
Good Pill will provide direct access to hundreds of life-saving medications and save families $150+/month on healthcare cost
Want to learn more about Free and Charitable Clinics, Charitable Pharmacies and the medically underserved?
An opportunity for charitable pharmacies to collaborate with oncology practices for non-oncology medications during and after treatment.
Charitable Pharmacies of America organization member receives Health Equity grant
Healthy People 2030 Leveraging Healthy People to Advance Health Equity Health equity is the attainment of the highest level of health for all people. “Eliminate health disparities, achieve health equity, and attain health literacy to improve the health and well-being of all.”
APPLICATIONS ARE OPEN! – Letters of Intent due 9/15/23
Recent federal legislative and regulatory updates in managed care pharmacy have prioritized topics ranging from expedited access to novel therapeutics to the health disparities and equity concerns affecting patient populations nationwide, but progress on these developments will depend on the impact of the midterm elections

